Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty

Acta Orthopaedica Scandinavica

Volumn 71, Issue 3, 2000, Pages 250-254

  Benoni, Göran ^a   Lethagen, Stefan ^a   Nilsson, Paul ^a   Fredin, Hans ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EPHEDRINE; NONSTEROID ANTIINFLAMMATORY AGENT; TRANEXAMIC ACID;

AGED; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HIP ARTHROPLASTY; HUMAN; MALE; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; POSTOPERATIVE THROMBOSIS; RANDOMIZED CONTROLLED TRIAL;

EID: 0033848970     PISSN: 00016470     EISSN: None     Source Type: Journal    
DOI: 10.1080/000164700317411834     Document Type: Article

References (18)

1. Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty
2. Letter to the Editor
3. Low- or high-vacuum drains in hip arthroplasty? A randomized study of 73 patients
4. Application of pharmacokinetic data from healthy volunteers for the prediction of plasma concentrations of tranexamic acid in surgical patients
5. Does tranexamic acid reduce blood loss in knee arthroplasty?
6. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement
7. Transcardiac echocardiography during invasive intramedullary procedures
8. Medullary lavage reduces embolic phenomena and cardiopulmonary changes during cemented hemiarthroplasty
9. Measurement of blood loss in clinical studies
10. Antifibrinolytic therapy with Cyklokapron in connection with prostatectomy. A double-blind study
11. Tranexamic acid (Cyklokapron) reduces perioperative blood loss associated with total knee arthroplasty
12. Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty
13. Letter to the Editor
14. High-dose aprotinin reduces blood loss in patients undergoing total hip replacement surgery
15. Aprotinin decreases blood loss in patients undergoing revision or bilateral total hip arthroplasty
16. Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: Double-blind randomised comparison of enoxaparin versus placebo
17. Blood-sparing drugs: Aprotinin, tranexamic acid and epsilon-aminocaproic acid
18. Comparing ultrasonography, magnetic resonance imaging and scintigraphy in evaluating an experimentally-induced muscular hematoma